Unknown

Dataset Information

0

Nanoscale Metal-Organic Framework with an X-ray Triggerable Prodrug for Synergistic Radiotherapy and Chemotherapy.


ABSTRACT: As heavy-metal-based nanoscale metal-organic frameworks (nMOFs) are excellent radiosensitizers for radiotherapy via enhanced energy deposition and reactive oxygen species (ROS) generation, we hypothesize that nMOFs with covalently conjugated and X-ray triggerable prodrugs can harness the ROS for on-demand release of chemotherapeutics for chemoradiotherapy. Herein, we report the design of a novel nMOF, Hf-TP-SN, with an X-ray-triggerable 7-ethyl-10-hydroxycamptothecin (SN38) prodrug for synergistic radiotherapy and chemotherapy. Upon X-ray irradiation, electron-dense Hf12 secondary building units serve as radiosensitizers to enhance hydroxyl radical generation for the triggered release of SN38 via hydroxylation of the 3,5-dimethoxylbenzyl carbonate followed by 1,4-elimination, leading to 5-fold higher release of SN38 from Hf-TP-SN than its molecular counterpart. As a result, Hf-TP-SN plus radiation induces significant cytotoxicity to cancer cells and efficiently inhibits tumor growth in colon and breast cancer mouse models.

SUBMITTER: Xu Z 

PROVIDER: S-EPMC10472429 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nanoscale Metal-Organic Framework with an X-ray Triggerable Prodrug for Synergistic Radiotherapy and Chemotherapy.

Xu Ziwan Z   Zhen Wenyao W   McCleary Caroline C   Luo Taokun T   Jiang Xiaomin X   Peng Cheng C   Weichselbaum Ralph R RR   Lin Wenbin W  

Journal of the American Chemical Society 20230815 34


As heavy-metal-based nanoscale metal-organic frameworks (nMOFs) are excellent radiosensitizers for radiotherapy via enhanced energy deposition and reactive oxygen species (ROS) generation, we hypothesize that nMOFs with covalently conjugated and X-ray triggerable prodrugs can harness the ROS for on-demand release of chemotherapeutics for chemoradiotherapy. Herein, we report the design of a novel nMOF, Hf-TP-SN, with an X-ray-triggerable 7-ethyl-10-hydroxycamptothecin (SN38) prodrug for synergist  ...[more]

Similar Datasets

| S-EPMC9462448 | biostudies-literature
| S-EPMC8159451 | biostudies-literature
| S-EPMC5673483 | biostudies-literature
| S-EPMC6193046 | biostudies-literature
| S-EPMC8899015 | biostudies-literature
| S-EPMC6003951 | biostudies-literature
| S-EPMC6681452 | biostudies-literature
| S-EPMC5666692 | biostudies-literature
| S-EPMC7852401 | biostudies-literature
| S-EPMC8414475 | biostudies-literature